Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy

Bernardini, Jonathan P; Brouwer, Jason M; Tan, Iris KL; Sandow, Jarrod J; Huang, Shuai; Stafford, Che A; Bankovacki, Aleksandra; Riffkin, Christopher D; Wardak, Ahmad Z; Czabotar, Peter E; Lazarou, Michael; Dewson, Grant

Author(s): Bernardini, Jonathan P; Brouwer, Jason M; Tan, Iris KL; Sandow, Jarrod J; Huang, Shuai; Stafford, Che A; Bankovacki, Aleksandra; Riffkin, Christopher D; Wardak, Ahmad Z; Czabotar, Peter E; Lazarou, Michael; Dewson, Grant;
Details: Publication Year 2018-12-20,Volume 38,Issue #2,Page pii: e99916
Journal Title: EMBO Journal
Publication Type: Journal Article
Abstract: Abstract The E3 ubiquitin ligase Parkin is a key effector of the removal of damaged mitochondria by mitophagy. Parkin determines cell fate in response to mitochondrial damage, with its loss promoting early onset Parkinson's disease and potentially also cancer progression. Controlling a cell's apoptotic response is essential to co-ordinate the removal of damaged mitochondria. We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove, a region that is crucial for BAK activation by BH3-only proteins and its homo-dimerisation during apoptosis. Ubiquitination inhibited BAK activity by impairing its activation and the formation of lethal BAK oligomers. Parkin also suppresses BAX-mediated apoptosis, but in the absence of BAX ubiquitination suggesting an indirect mechanism. In addition, we find that BAK-dependent mitochondrial outer membrane permeabilisation during apoptosis promotes PINK1-dependent Parkin activation. Hence, we propose that Parkin directly inhibits BAK to suppress errant apoptosis, thereby allowing the effective clearance of damaged mitochondria, but also promotes clearance of apoptotic mitochondria to limit their potential pro-inflammatory effect.
Publisher: WIley
Research Division(s): Cell Signalling And Cell Death; Structural Biology; Systems Biology And Personalised Medicine; Cancer And Haematology
Publisher's Version: https://doi.org/doi:10.15252/embj.201899916
NHMRC Grants: NHMRC/GNT1106471, NHMRC/1079700, NHMRC/1078924,
ARC Grants: ARC/FT160100063, ARC/FT100100791,
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2019-01-14 12:35:27

Last Modified: 2019-12-03 02:53:40